Canergy 100 mg tablets for dogs

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

DSU DSU (DSU)
30-01-2024

Active ingredient:

Propentofylline

Available from:

Le Vet Beheer B.V.

ATC code:

QC04AD90

INN (International Name):

Propentofylline

Dosage:

100 mg/tablet

Pharmaceutical form:

Tablet

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Dogs

Therapeutic area:

propentofylline

Therapeutic indications:

Cardiovascular

Authorization status:

Authorised

Authorization date:

2015-05-29

Summary of Product characteristics

                                Health Products Regulatory Authority
06 April 2020
CRN009CCD
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Canergy 100 mg tablets for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Propentofylline 100 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Light brown with brown spots, round and convex flavoured tablet with a
cross-shaped break line on one side.
The tablets can be divided into 2 or 4 equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the improvement of peripheral and cerebral vascular blood
circulation. For improvement in dullness, lethargy and overall
demeanour in dogs.
4.3 CONTRAINDICATIONS
Do not use in dogs weighing less than 5 kg.
Do not use in known cases of hypersensitivity to the active substance
or to any of the excipients.
See also section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Specific diseases (e.g. kidney disease) should be treated accordingly.
Consideration should be given to rationalising the medication of dogs
already receiving treatment for congestive heart failure
or bronchial disease.
In the case of renal failure, the dose should be reduced.
The tablets are flavoured. In order to avoid any accidental ingestion,
store tablets out of reach of the animals.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Care should be taken to avoid accidental ingestion.
In the event of accidental ingestion of the tablets, seek medical
advice immediately and show the package leaflet or the label
to the physician. Wash hands after use.
Health Products Regulatory Authority
06 April 2020
CRN009CCD
Page 2 of 4
Any unused tablet portion should be returned to the open blister and
inserted back into the carton to be used for the next
administration.
4.6 ADVERSE REACTIONS (F
                                
                                Read the complete document
                                
                            

Search alerts related to this product